These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3133853)

  • 1. Pharmacologic and immunologic agonists and antagonists of cyclosporine.
    Tilney NL; Strom TB; Kupiec-Weglinski JW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):13-22. PubMed ID: 3133853
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation.
    Padberg WM; Di Stefano R; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1987 Oct; 19(5):4234-5. PubMed ID: 3118539
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
    Kupiec-Weglinski JW; Hahn HJ; Kirkman RL; Volk HD; Mouzaki A; DiStefano R; Tellides G; Dallman M; Morris PJ; Strom TB
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):207-16. PubMed ID: 3129841
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic interaction of cyclosporine A with interleukin 2 receptor monoclonal antibody therapy.
    Tellides G; Dallman MJ; Morris PJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):202-6. PubMed ID: 3129840
    [No Abstract]   [Full Text] [Related]  

  • 5. New developments in renal transplantation.
    Merkel FK; Jensik SC
    Compr Ther; 1981 Mar; 7(3):6-13. PubMed ID: 7016421
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological profile of high-risk patients treated with different types of immunosuppressive therapy].
    Molajoni ER; Cinti P; Bachetoni A; Sallusto F; Orlandini A; Alfani D; Cortesini R
    Ann Ist Super Sanita; 1987; 23(4):947-50. PubMed ID: 3330653
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
    Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
    Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toward individualized immunosuppression].
    Grinyó JM
    Nefrologia; 2001; 21(3):232. PubMed ID: 11471302
    [No Abstract]   [Full Text] [Related]  

  • 10. An appraisal of drug interactions with Sandimmun.
    Cockburn IT; Krupp P
    Transplant Proc; 1989 Oct; 21(5):3845-50. PubMed ID: 2683269
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of cyclosporine in cadaveric renal transplantation in China.
    Xie T; Xu QJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):99-101. PubMed ID: 3291336
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of unresponsiveness via intrathymic inoculation.
    Propper D
    Lancet; 1991 Jun; 337(8755):1487-8. PubMed ID: 1675358
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation.
    Karmi SA; DePalma R; Bosch J; Dosa S; Michell A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):110-3. PubMed ID: 3291218
    [No Abstract]   [Full Text] [Related]  

  • 15. PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats.
    Ryffel B; Donatsch P; Hiestand P; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S95-9. PubMed ID: 3458551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective study of conversion from cyclosporine to azathioprine: comparison of clinical and morphologic findings.
    Abbud-Filho M; Ramalho HJ; Barberato JB; Corrente JE; Salgueiro MC; Mazzetto MR; Bezas AG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):164-8. PubMed ID: 3291235
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal transplants maintained on low-dose cyclosporine and prednisolone.
    Rogerson ME; Neild GH; Rudge CJ; Wood SM; Cairns HS; Mansell MA; Thompson FD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):114-6. PubMed ID: 3291222
    [No Abstract]   [Full Text] [Related]  

  • 19. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment.
    Cantarovich F; Cantarovich D; Touraine JL; Tizado J; Castro LZ; Correa C; Herman AP; Traeger J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):402-6. PubMed ID: 3284084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.